Many women with early-stage breast cancer may be able to skip chemotherapy, according to a new study.
A gene test called “Oncotype D-X” has been guiding doctors for years on whether women need chemo if they have receptor-positive, her-2negative, early-stage breast cancer that hasn’t spread.
A low test score means patients can forgo the treatment – as well as its toxic side effects – while a high score means women would greatly benefit.
For years – doctors were unsure how to treat women who fell in the middle range of the scoring system.
Now, research on more than 10,000 patients finds those mid-range women can safely be spared chemotherapy – without affecting survival.
Experts say these findings will change treatment practices immediately.
- Study: Early-Stage Breast Cancer Patients Can Possibly Skip Chemotherapy
- A cancer patient quarantined on a cruise ship fears she won't make it home for her chemotherapy
- American Cancer Society launches 'I can fight breast cancer' campaign
- 'Fight against breast cancer' walk at Bidwell Park
- Redding First Responders go Pink for Breast Cancer Awareness
- CHP Hosting 'Tip a Chippie' for Breast Cancer Awareness Month
- Tip a CHiPPie Event Raises Money for Breast Cancer Initiatives
- Redding prepares for 'Think Pink' to promote breast cancer awareness
- Chico Police Wear Pink for Breast Cancer Awareness